Medication-Related Osteonecrosis
Jasjit Dillon, MBBS, DDS, FDSRCS, FACS
The time period for obtaining CE/CME credits for this webinar has passed. You may still access the webinar, but you will no longer be able to receive CE/CME credit for it.
Abstract
You have been referred a 65 female on a bisphosphonate for an extraction and immediate dental implant on #19. What is the best way to proceed? The patient wants to know her risk of medication-related osteonecrosis of the jaws (MRONJ) and what you will do to reduce it? This comprehensive overview
of MRONJ will cover this and more. It will review medications that cause MRONJ and which ones are more problematic, along with the frequency and risk of disease. It will review risk and prevention strategies. The staging and current management including the latest research and clinical trials, and future treatment therapies will also be reviewed.
Learning Objectives
- Understand the etiology and risk of developing MRONJ
- Understand the risk of MRONJ with different classes of drugs
- Be aware of future preventative research in the management of MRONJ